Minerva Neurosciences (NERV) Non Operating Income (2014 - 2018)
Minerva Neurosciences (NERV) posted Non Operating Income of -$4018.0 for Q3 2018, up 88.77% on a QoQ basis from -$35781.0 in Q2 2018, and up 97.09% year-over-year from -$2038.7 in Q3 2017.
Minerva Neurosciences (NERV) Non Operating Income (2014 - 2018) Analysis & Trends
Minerva Neurosciences' Non Operating Income history runs 5 years deep, the most recent figure standing at -$4018.0 for Q3 2018.
- Quarterly Non Operating Income rose 97.09% year-over-year to -$4018.0 in Q3 2018, while the trailing twelve-month figure through Dec 2018 was -$110448.0 (up 82.02% YoY) and the FY2018 annual result came in at -$110448.0, up 82.02% from the prior year.
- Non Operating Income was -$4018.0 for Q3 2018 at Minerva Neurosciences, up from -$35781.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3.0 in Q4 2014 and bottomed at -$1.7 million in Q2 2014.
- A 5-year average of -$252706.9 and a median of -$216105.5 in 2015 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2015 — Non Operating Income slumped 9222433.33% — and 2018, when it surged 97.09%.
- Minerva Neurosciences' Non Operating Income stood at $3.0 in 2014, then slumped by 9222433.33% to -$276670.0 in 2015, then rose by 16.02% to -$232358.0 in 2016, then surged by 54.92% to -$104738.0 in 2017, then surged by 96.16% to -$4018.0 in 2018.
- Business Quant data shows NERV's Non Operating Income at -$4018.0 in Q3 2018, -$35781.0 in Q2 2018, and -$70649.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -4,018.00 |
| Jun 30, 2018 | -35,781.00 |
| Mar 31, 2018 | -70,649.00 |
| Dec 31, 2017 | -104,738.00 |
| Sep 30, 2017 | -137,899.00 |
| Jun 30, 2017 | -170,125.00 |
| Mar 31, 2017 | -201,502.00 |
| Dec 31, 2016 | -232,358.00 |
| Sep 30, 2016 | -258,764.00 |
| Jun 30, 2016 | -268,256.00 |
| Mar 31, 2016 | -270,356.00 |
| Dec 31, 2015 | -276,670.00 |
| Sep 30, 2015 | -269,950.00 |
| Jun 30, 2015 | -275,742.00 |
| Mar 31, 2015 | -230,709.00 |
| Dec 31, 2014 | 3.00 |
| Sep 30, 2014 | -14,835.00 |
| Jun 30, 2014 | -1.73 Mn |